Sec. 5. Department of Health and Human Services
285 words·~1 min read·
/bill/116/hr/3652/ih/section-5A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary of Health and Human Services acting through the Director of the National Institute of Allergy and Infectious Diseases (in this subsection referred to as the Secretary ) shall conduct a study that examines— the presence of pathogens in hemp-based and hemp-blended products; and the impact of that presence on the health and safety of consumers of such products. Not later than 1 year after the date of enactment of this Act, the Secretary shall— submit to Congress a report on the results of the study conducted under paragraph (1), including recommendations for nullifying any negative impacts of pathogens in hemp-based and hemp-blended products on the health and safety of consumers of the products; and make such report publicly available on the website of the Department of Health and Human Services.
In this subsection, the term pathogen means a mold, mildew, fungus, yeast, virus, or other microorganism that can cause disease or illness. The Secretary of Health and Human Services shall identify and conduct a study on commodities purchased by the health care industry for which hemp-based and hemp-blended products may be substituted, including— materials and equipment (such as bedding, curtains, uniforms, building materials, body care supplies, and industrial cleaning supplies) used in health care delivery settings (including hospitals, clinics, and health centers); and materials and equipment used to create, store, or administer prescription drugs and durable medical equipment.
Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services shall— submit to the Congress a report on the results of the study conducted under paragraph (1); and make such report publicly available on the website of the Department of Health and Human Services.